This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zutter, M. M. Articles by Santoro, S. A. Search for Related Content PubMed PubMed Citation Articles by Zutter, M. M. Articles by Santoro, S. A.

American Journal of Pathology, Vol 142, 1439-1448, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Altered integrin expression in adenocarcinoma of the breast. Analysis by in situ hybridization

MM Zutter, HR Krigman and SA Santoro
Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110.

The integrin superfamily of adhesion receptors mediates interactions between cells and the extracellular matrix. Our earlier immunohistochemical analysis showed that normal mammary epithelium expressed high levels of the alpha 2 beta 1 collagen/laminin receptor and intermediate levels of the alpha 5 beta 1 fibronectin receptor. In contrast, malignant cells of adenocarcinoma of the breast exhibited marked diminution or loss of the alpha 2 beta 1 and alpha 5 beta 1 integrins. We have now evaluated the level of alpha 2, alpha 5, and beta 1 integrin subunit messenger (m)RNA by in situ hybridization in adenocarcinoma of the breast. Normal breast ducts and ductules expressed high levels of all three integrin subunit mRNAs. Poorly differentiated lesions expressed low to undetectable levels of alpha 2, alpha 5, and beta 1 mRNA. Well- and moderately differentiated lesions expressed all three subunits at intermediate levels. Thus, decreased expression of the alpha 2 beta 1 and alpha 5 beta 1 integrins in mammary carcinoma is the result of decreased steady-state integrin subunit mRNA levels due to altered expression of the integrin genes.

This article has been cited by other articles:

				C. C. Park, H. Zhang, M. Pallavicini, J. W. Gray, F. Baehner, C. J. Park, and M. J. Bissell {beta}1 Integrin Inhibitory Antibody Induces Apoptosis of Breast Cancer Cells, Inhibits Growth, and Distinguishes Malignant from Normal Phenotype in Three Dimensional Cultures and In vivo Cancer Res., February 1, 2006; 66(3): 1526 - 1535. [Abstract] [Full Text] [PDF]

				L. Zhang, M. Bewick, and R. M. Lafrenie Role of Raf-1 and FAK in cell density-dependent regulation of integrin-dependent activation of MAP kinase Carcinogenesis, July 1, 2002; 23(7): 1251 - 1258. [Abstract] [Full Text] [PDF]

				D. Taverna and R. O. Hynes Reduced Blood Vessel Formation and Tumor Growth in {{alpha}}5-Integrin-negative Teratocarcinomas and Embryoid Bodies Cancer Res., July 1, 2001; 61(13): 5255 - 5261. [Abstract] [Full Text] [PDF]

				P.J. SIMPSON-HAIDARIS and B. RYBARCZYK Tumors and Fibrinogen: The Role of Fibrinogen as an Extracellular Matrix Protein Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 406 - 425. [Abstract] [Full Text] [PDF]

				G. J. Mizejewski Role of Integrins in Cancer: Survey of Expression Patterns Experimental Biology and Medicine, November 1, 1999; 222(2): 124 - 138. [Abstract] [Full Text]

				M. V. Carriero, S. D. Vecchio, M. Capozzoli, P. Franco, L. Fontana, A. Zannetti, G. Botti, G. D'Aiuto, M. Salvatore, and M. P. Stoppelli Urokinase Receptor Interacts with {{alpha}}v{{beta}}5 Vitronectin Receptor, Promoting Urokinase-dependent Cell Migration in Breast Cancer Cancer Res., October 1, 1999; 59(20): 5307 - 5314. [Abstract] [Full Text] [PDF]

				M. M. Zutter, S. A. Santoro, J. E. Wu, T. Wakatsuki, S. K. Dickeson, and E. L. Elson Collagen Receptor Control of Epithelial Morphogenesis and Cell Cycle Progression Am. J. Pathol., September 1, 1999; 155(3): 927 - 940. [Abstract] [Full Text] [PDF]

				D. Wang, L. Sun, E. Zborowska, J. K. V. Willson, J. Gong, J. Verraraghavan, and M. G. Brattain Control of Type II Transforming Growth Factor-beta Receptor Expression by Integrin Ligation J. Biol. Chem., April 30, 1999; 274(18): 12840 - 12847. [Abstract] [Full Text] [PDF]

				D Alford, D Baeckstrom, M Geyp, P Pitha, and J Taylor-Papadimitriou Integrin-matrix interactions affect the form of the structures developing from human mammary epithelial cells in collagen or fibrin gels J. Cell Sci., January 2, 1998; 111(4): 521 - 532. [Abstract] [PDF]

				V.M. Weaver, O.W. Petersen, F. Wang, C.A. Larabell, P. Briand, C. Damsky, and M.J. Bissell Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies J. Cell Biol., April 7, 1997; 137(1): 231 - 245. [Abstract] [Full Text] [PDF]

				M. E. Doerr and J. I. Jones The Roles of Integrins and Extracellular Matrix Proteins in the Insulin-like Growth Factor I-stimulated Chemotaxis of Human Breast Cancer Cells J. Biol. Chem., February 2, 1996; 271(5): 2443 - 2447. [Abstract] [Full Text] [PDF]

				A. Howlett, N Bailey, C Damsky, O. Petersen, and M. Bissell Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma J. Cell Sci., January 5, 1995; 108(5): 1945 - 1957. [Abstract] [PDF]